Renewing questions about the safety of the medication.


Rosa DeLauro on Monday needed the diabetes medication Avandia to be pulled from the marketplace in the wake of two brand-new medical studies. At the same time, a study in the journal Cancers shows that for men who’ve undergone surgery for prostate cancer, statin use seems to reduce the chance that the condition will return. You can view the complete Kaiser Daily Health Plan Survey, search the archives, or join email delivery of in-depth coverage of health policy developments, debates and discussions.A complete of 84 percent of the patients receiving dasatinib and 81 percent of the individuals receiving imatinib continued to receive treatment for the duration of the analysis period reported in this post . Treatment is definitely ongoing; the protocol stipulates that an evaluation of the efficacy and safety data be performed after a minimum follow-up of 5 years. Efficacy The rate of a confirmed complete cytogenetic response by 12 weeks was significantly higher among patients receiving dasatinib than among patients receiving imatinib . The rate of a complete cytogenetic response by 12 months noticed on at least one assessment was also higher with dasatinib treatment than with imatinib treatment . The rate of a significant molecular response anytime was significantly higher among patients receiving dasatinib than among patients receiving imatinib .